Medx Health Corp
- LAST PRICE0.0950
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0950/ 3
- Ask / Lots0.1000/ 7
- Open / Previous Close0.0950 / 0.0950
- Day Range
- 52 Week Range
- Volume30,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDX |
|---|---|---|
| 09:34 ET | 30000 | 0.095 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Medx Health Corp | 24.8M | -3.3x | --- |
Treatment.com AI Inc | 27.5M | -2.0x | --- |
Groupe Ryah Inc | 11.1M | 2.3x | --- |
H-Source Holdings Ltd | 11.8M | -3.6x | --- |
VentriPoint Diagnostics Ltd | 34.5M | -7.1x | --- |
Theralase Technologies Inc | 36.7M | -7.9x | --- |
Company Information
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
Contact Information
- Headquarters
- 1495 Bonhill Road, Unit # 1 MississaugaMISSISSAUGA, ON, Canada L5T 1M2
- Phone
- 905-670-4428
- Fax
- 905-670-4749
Executives
- Independent Chairman of the Board
- Kenneth McKay
- Acting Chief Executive Officer, Director
- Stephen Lockyer
- Independent Vice Chairman of the Board
- David Hennigar
- Acting Chief Financial Officer, Corporate Secretary
- Christopher Freeman
- President - Dermatological Services and Products
- Michael Druhan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $24.8M |
|---|---|
Revenue (TTM) | $602.6K |
Shares Outstanding | 262.0M |
Medx Health Corp does not pay a dividend. | |
Beta | 1.35 |
EPS | $-0.03 |
Book Value | $-0.04 |
P/E Ratio | -3.3x |
Price/Sales (TTM) | 41.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -890.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
